Chiesi Farmaceutici SpA

15 products tracked · names used in filings: Chiesi Farmaceutici SpA, Chiesi Farmaceutici S.p.A, Chiesi Farmaceutici S.p.A.

Upcoming milestones

No upcoming milestones listed.

Recent milestones

No recent milestones.

Products

ProductStatusApproved
🇪🇺Elfabrio
pegunigalsidase alfa
Authorised2023-05-04
🇪🇺Filsuvez
birch bark extract
Authorised2022-06-21
🇪🇺Myalepta
metreleptin
Authorised2018-07-30
🇪🇺Trydonis
beclometasone;formoterol;glycopyrronium bromide
Authorised2018-04-26
🇪🇺Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)
beclometasone;formoterol
Withdrawn2018-04-23
🇪🇺Lamzede
velmanase alfa
Authorised2018-03-23
🇪🇺Trimbow
beclometasone;formoterol;glycopyrronium bromide
Authorised2017-07-17
🇪🇺Raxone
idebenone
Authorised2015-09-08
🇪🇺Quinsair
levofloxacin
Authorised2015-03-25
🇪🇺Kengrexal
cangrelor
Authorised2015-03-23
🇪🇺Envarsus
tacrolimus
Authorised2014-07-18
🇪🇺Procysbi
mercaptamine
Authorised2013-09-05
🇪🇺Lojuxta
lomitapide
Authorised2013-07-31
🇪🇺Peyona (previously Nymusa)
caffeine
Authorised2009-07-02
🇪🇺Ferriprox
deferiprone
Authorised1999-08-25

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.